The Curious Case Of GW Pharmaceuticals

In 2005, GW hired a vociferous medical marijuana opponent to help them distinguish their version of THC from medical cannabis. Here’s why that’s a problem.

Let me make clear that I do not have any problems with the “pharmaceuticalization” of cannabis. If the pharmaceutical companies can manipulate the molecules and/or combine cannabinoids with other substances and thereby help sick and dying people, or just make healthy people feel better and make a profit doing it, everyone wins.  

However, when a company uses marijuana prohibition and the Drug War to lobby for state violence against sick and dying people to try to monopolize medical access to a plant that has been used medically for millennia, I have to object.  

After GW Pharmaceuticals developed “Sativex”, its version of THC, it met with “skepticism” in the U.S. drug war establishment, basically the entire U.S. government, because if it was approved for use in the U.S., that would suggest that “marijuana” might actually have medical use. Heresy!! 

Read full here:

Leave a Reply

Your email address will not be published. Required fields are marked *